Abstract
Previously it has been shown that excitatory effects of 5-hydroxytryptamine (5-HT) upon interneurons in the rat piriform cortex are mediated by 5-HT2A receptors. This receptor is linked to phosphoinositide turnover, and one consequence of stimulating this receptor is the activation of protein kinase C (PKC). In the present study, the effect of PKC inhibitors on the 5-HT excitation of piriform cortical interneurons was examined by extracellular recording in a rat brain slice preparation. Bath application of the selective PKC inhibitors, bisindolymalemide and chelerythrine, and the nonselective protein kinase inhibitor, H-7, all enhanced the excitatory effects of 5-HT. Two other nonselective protein kinase inhibitors, H-8 and HA 1004, which are 2.5-fold and 6.7-fold less potent than H-7 at inhibiting PKC, produced a slight or no enhancement, respectively, of the excitatory effect of 5-HT. Bisindolylmalemide, chelerytrine, and H-7 did not enhance the excitatory effects of norepinephrine or carbachol on the same interneurons. The PKC activator phorbol 12, 13-diacetate (PDA) decreased the excitatory effect of 5-HT; this decrease was rapidly reversed by H-7. As inhibitors of PKC selectively enhanced rather than blocked the excitation...Continue Reading
References
Oct 1, 1991·The Journal of Physiology·D A McCormick, Z Wang
Nov 1, 1991·Synapse·P W Sheldon, G K Aghajanian
Jan 1, 1990·Brain Research·P W Sheldon, G K Aghajanian
Jul 30, 1990·Brain Research·G K Aghajanian
Nov 15, 1990·Biochemical and Biophysical Research Communications·J M HerbertJ P Maffrand
Dec 1, 1989·British Journal of Pharmacology·C N Scholfield, A J Smith
Dec 7, 1989·European Journal of Pharmacology·C R AshbyR Y Wang
Dec 1, 1989·British Journal of Pharmacology·R CorradettiN Ropert
Oct 1, 1989·The Journal of Physiology·R A North, N Uchimura
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K HosodaY Nishizuka
Jan 1, 1989·Synapse·G K Aghajanian, K Rasmussen
Jun 1, 1984·The Biochemical Journal·M J Berridge
Jun 11, 1984·FEBS Letters·D de Chaffoy de CourcellesH van Belle
Oct 9, 1984·Biochemistry·H HidakaY Sasaki
Aug 1, 1984·Neuropharmacology·P J Conn, E Sanders-Bush
Jun 27, 1994·Brain Research·P Fan
Jul 1, 1994·European Journal of Pharmacology·G J Marek, G K Aghajanian
Jan 1, 1994·Annual Review of Pharmacology and Toxicology·K P Minneman, T A Esbenshade
Apr 15, 1994·European Journal of Pharmacology·D M Helmeste, S W Tang
Jan 1, 1994·Annual Review of Neuroscience·D E Clapham
Jan 8, 1993·Brain Research·R L Gellman, G K Aghajanian
Feb 1, 1993·Synapse·J C GarrattG K Aghajanian
Citations
Jan 1, 1996·Life Sciences·M T SalvadorM J Rodríguez-Yoldi
Dec 4, 1998·Biological Psychiatry·G J Marek, G K Aghajanian
Mar 26, 2003·Life Sciences·Dirk Van OekelenJosée E Leysen
Nov 14, 1997·Neuroscience and Biobehavioral Reviews·L Uphouse
Dec 24, 2008·The Journal of Biological Chemistry·Ryan T StrachanBryan L Roth
Aug 1, 2014·Behavioural Brain Research·Davide Amato
May 12, 2007·Neuropharmacology·Efrain E GarciaElaine Sanders-Bush
Jul 13, 1999·Journal of Neurophysiology·D G Rainnie